Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (243)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
12
2025
533
1.180
 Why?
Germ-Line Mutation
9
2013
67
0.980
 Why?
Hamartoma Syndrome, Multiple
8
2012
16
0.980
 Why?
PTEN Phosphohydrolase
13
2015
55
0.950
 Why?
Barrett Esophagus
2
2019
30
0.930
 Why?
Esophageal Neoplasms
2
2019
113
0.840
 Why?
Adenocarcinoma
3
2019
405
0.770
 Why?
Haplotypes
3
2020
96
0.710
 Why?
Homozygote
3
2019
57
0.610
 Why?
Polymorphism, Single Nucleotide
9
2021
505
0.610
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
175
0.570
 Why?
Proto-Oncogene Proteins c-akt
4
2012
171
0.540
 Why?
Databases, Factual
1
2020
742
0.510
 Why?
Capacity Building
2
2025
26
0.430
 Why?
Alleles
6
2021
277
0.420
 Why?
Smoke-Free Policy
2
2025
17
0.420
 Why?
Heart Defects, Congenital
3
2025
625
0.410
 Why?
Lung Neoplasms
3
2020
645
0.400
 Why?
Phosphatidylinositol 3-Kinases
2
2012
148
0.380
 Why?
Genotype
6
2021
563
0.370
 Why?
Extracellular Matrix Proteins
1
2011
69
0.340
 Why?
Scavenger Receptors, Class A
1
2011
43
0.340
 Why?
Case-Control Studies
6
2025
1212
0.330
 Why?
Humans
40
2025
53230
0.290
 Why?
Transcription Factors
1
2011
571
0.270
 Why?
Genetic Variation
3
2021
223
0.270
 Why?
Breast Neoplasms
7
2017
1222
0.270
 Why?
Thyroid Neoplasms
4
2012
113
0.260
 Why?
Inositol
1
2025
19
0.240
 Why?
Tobacco Smoke Pollution
2
2025
56
0.240
 Why?
Adult
18
2025
14534
0.230
 Why?
Female
24
2025
28782
0.230
 Why?
Limb Deformities, Congenital
1
2025
15
0.230
 Why?
Genes, Wilms Tumor
1
2005
1
0.230
 Why?
Population
1
2005
8
0.230
 Why?
Gene Frequency
3
2020
97
0.230
 Why?
Social Justice
1
2025
34
0.220
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
20
0.220
 Why?
Genome
2
2019
58
0.220
 Why?
Lamin Type A
1
2024
5
0.220
 Why?
Evidence-Based Practice
1
2025
113
0.220
 Why?
Middle Aged
17
2025
13419
0.210
 Why?
Exome
2
2025
54
0.200
 Why?
Linkage Disequilibrium
2
2020
41
0.200
 Why?
Dietary Supplements
1
2025
479
0.180
 Why?
DNA Methylation
2
2024
592
0.170
 Why?
Male
16
2025
27435
0.170
 Why?
Inheritance Patterns
1
2021
22
0.170
 Why?
Models, Genetic
5
2013
169
0.170
 Why?
Phenotype
7
2021
803
0.170
 Why?
Risk Factors
5
2019
4017
0.160
 Why?
Succinate Dehydrogenase
2
2011
22
0.160
 Why?
Stilbenes
2
2010
58
0.160
 Why?
Young Adult
9
2025
4511
0.160
 Why?
Fires
1
2020
16
0.160
 Why?
Agriculture
1
2020
19
0.160
 Why?
Aged
11
2020
10429
0.160
 Why?
Cluster Analysis
4
2013
237
0.150
 Why?
Tobacco Products
1
2021
142
0.150
 Why?
Social Media
1
2021
125
0.150
 Why?
Aged, 80 and over
5
2020
3494
0.150
 Why?
Arkansas
5
2025
2068
0.150
 Why?
Genomics
1
2020
271
0.140
 Why?
Cell Proliferation
3
2010
1031
0.140
 Why?
Prostatic Neoplasms
2
2012
401
0.130
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
152
0.130
 Why?
Gene Expression Regulation, Neoplastic
3
2010
868
0.130
 Why?
Prognosis
2
2020
2118
0.130
 Why?
Endometrial Neoplasms
2
2015
143
0.120
 Why?
Leprosy
1
2016
8
0.120
 Why?
Hypertension
1
2021
554
0.120
 Why?
Emergency Service, Hospital
1
2020
530
0.120
 Why?
Asthma
1
2020
319
0.120
 Why?
Regression Analysis
2
2017
391
0.110
 Why?
Microsatellite Repeats
2
2012
41
0.110
 Why?
Smoking
2
2025
526
0.110
 Why?
Tuberculosis
1
2016
133
0.110
 Why?
Aromatase
1
2015
9
0.110
 Why?
Genetic Linkage
2
2011
25
0.100
 Why?
Sirolimus
2
2010
72
0.100
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
3
0.100
 Why?
Adolescent
8
2021
6907
0.100
 Why?
Genome-Wide Association Study
2
2012
184
0.100
 Why?
Smad4 Protein
1
2013
6
0.100
 Why?
Genetic Testing
2
2010
130
0.100
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
20
0.100
 Why?
Cohort Studies
3
2012
1557
0.100
 Why?
Colonic Polyps
1
2013
39
0.090
 Why?
United States
4
2025
5409
0.090
 Why?
Receptors, Cell Surface
1
2013
109
0.090
 Why?
Mitochondrial Diseases
1
2012
45
0.090
 Why?
Codon, Nonsense
1
2012
27
0.090
 Why?
Flavin-Adenine Dinucleotide
1
2011
5
0.090
 Why?
Antigens, CD
1
2013
217
0.090
 Why?
NAD
1
2011
45
0.090
 Why?
Genes, p53
1
2011
51
0.090
 Why?
DNA, Neoplasm
1
2012
146
0.090
 Why?
Mutation, Missense
1
2012
110
0.090
 Why?
Siblings
1
2011
35
0.090
 Why?
Adenoma
1
2012
114
0.090
 Why?
Taxoids
1
2011
38
0.090
 Why?
Risk
1
2012
306
0.090
 Why?
Gene Expression Profiling
3
2012
1112
0.080
 Why?
Software
1
2013
280
0.080
 Why?
Intestinal Polyps
1
2010
7
0.080
 Why?
Receptors, Androgen
1
2010
48
0.080
 Why?
Cephalometry
1
2010
18
0.080
 Why?
Colorectal Neoplasms
2
2012
302
0.080
 Why?
Tumor Microenvironment
1
2012
274
0.080
 Why?
Gene Dosage
1
2009
76
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
54
0.080
 Why?
Head
1
2010
72
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
136
0.080
 Why?
Patient Selection
1
2010
273
0.070
 Why?
Cell Communication
1
2009
73
0.070
 Why?
Age Factors
1
2012
1136
0.070
 Why?
Immunohistochemistry
1
2011
975
0.070
 Why?
Urinary Bladder Neoplasms
1
2010
167
0.070
 Why?
Drug Resistance, Neoplasm
1
2011
350
0.070
 Why?
Chromosome Mapping
2
2021
145
0.070
 Why?
Prospective Studies
4
2017
2411
0.070
 Why?
Prevalence
2
2021
1034
0.060
 Why?
Mass Screening
1
2010
362
0.060
 Why?
Rural Population
2
2022
596
0.060
 Why?
Cell Line, Tumor
4
2011
1470
0.060
 Why?
Physical Chromosome Mapping
1
2005
7
0.060
 Why?
Antineoplastic Agents
2
2011
1232
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
2
0.060
 Why?
DNA Copy Number Variations
1
2025
117
0.050
 Why?
Exons
1
2005
100
0.050
 Why?
Counseling
1
2025
141
0.050
 Why?
Child
5
2020
7379
0.050
 Why?
CpG Islands
1
2024
114
0.050
 Why?
Models, Theoretical
1
2005
180
0.050
 Why?
Gene Expression Regulation
1
2008
1003
0.050
 Why?
Mutation
2
2010
1337
0.050
 Why?
Logistic Models
1
2025
947
0.050
 Why?
Biopsy
1
2005
600
0.050
 Why?
Polyproteins
1
2022
3
0.050
 Why?
Smoking Cessation
1
2025
325
0.050
 Why?
Child, Preschool
3
2020
4162
0.050
 Why?
RNA, Viral
1
2022
123
0.040
 Why?
Risk Assessment
2
2021
1368
0.040
 Why?
Phosphoproteins
1
2022
117
0.040
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
6
0.040
 Why?
United States Food and Drug Administration
1
2021
93
0.040
 Why?
Membrane Glycoproteins
1
2022
238
0.040
 Why?
Nutrition Surveys
1
2021
118
0.040
 Why?
Loss of Heterozygosity
2
2012
78
0.040
 Why?
Stromal Cells
2
2012
77
0.040
 Why?
Nicotine
1
2021
180
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
83
0.040
 Why?
Self Report
1
2021
225
0.040
 Why?
Pedigree
2
2010
128
0.040
 Why?
Seasons
1
2020
92
0.040
 Why?
Odds Ratio
1
2021
567
0.040
 Why?
Air Pollution
1
2020
49
0.040
 Why?
Neoplasms
1
2009
1334
0.040
 Why?
Signal Transduction
3
2010
1748
0.040
 Why?
Phosphorylation
2
2010
533
0.040
 Why?
Gene Expression
2
2012
618
0.040
 Why?
Sensitivity and Specificity
2
2012
867
0.040
 Why?
Predictive Value of Tests
2
2012
934
0.040
 Why?
Pregnancy
1
2025
2608
0.040
 Why?
Infant, Newborn
1
2025
2913
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
1367
0.030
 Why?
Infant
2
2020
3805
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Angiopoietin-2
1
2017
17
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
189
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
Cross-Sectional Studies
1
2021
1723
0.030
 Why?
Neoadjuvant Therapy
1
2017
124
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
51
0.030
 Why?
Pilot Projects
1
2016
726
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.020
 Why?
Databases, Genetic
1
2013
82
0.020
 Why?
Genome, Human
1
2013
121
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Penetrance
1
2012
7
0.020
 Why?
Neoplasm Grading
1
2012
128
0.020
 Why?
Genetic Association Studies
1
2012
124
0.020
 Why?
Vincristine
1
2011
89
0.020
 Why?
Anthracyclines
1
2011
35
0.020
 Why?
Inhibitory Concentration 50
1
2010
75
0.020
 Why?
Formazans
1
2010
2
0.020
 Why?
Immunoblotting
1
2010
118
0.020
 Why?
Tetrazolium Salts
1
2010
13
0.020
 Why?
Paclitaxel
1
2011
91
0.020
 Why?
Androgen Antagonists
1
2010
13
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
84
0.020
 Why?
Drug Synergism
1
2010
147
0.020
 Why?
HEK293 Cells
1
2011
235
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
152
0.020
 Why?
Epithelial Cells
1
2012
218
0.020
 Why?
Michigan
1
2010
26
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
 Why?
Point Mutation
1
2010
67
0.020
 Why?
Neoplasm Transplantation
1
2010
86
0.020
 Why?
Kidney Neoplasms
1
2012
181
0.020
 Why?
Androgens
1
2010
70
0.020
 Why?
Transplantation, Heterologous
1
2010
78
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
Adenosine Triphosphate
1
2011
211
0.020
 Why?
BRCA2 Protein
1
2009
19
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
73
0.020
 Why?
Polymerase Chain Reaction
1
2011
452
0.020
 Why?
Comparative Genomic Hybridization
1
2009
38
0.020
 Why?
Mice, Nude
1
2010
232
0.020
 Why?
Proteins
1
2012
351
0.020
 Why?
BRCA1 Protein
1
2009
39
0.020
 Why?
Chi-Square Distribution
1
2010
291
0.020
 Why?
Cell Cycle
1
2010
237
0.020
 Why?
Protein Binding
1
2011
670
0.020
 Why?
Algorithms
1
2013
667
0.020
 Why?
Gene Deletion
1
2010
279
0.020
 Why?
Diagnosis, Differential
1
2012
1038
0.020
 Why?
Cell Survival
1
2010
600
0.020
 Why?
Neoplastic Stem Cells
1
2009
90
0.020
 Why?
Promoter Regions, Genetic
1
2010
465
0.020
 Why?
Neoplasm Invasiveness
1
2009
281
0.020
 Why?
Incidence
1
2012
1085
0.020
 Why?
Neoplasm Staging
1
2011
774
0.020
 Why?
Microscopy, Confocal
1
2008
75
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
412
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
187
0.020
 Why?
Membrane Proteins
1
2010
333
0.020
 Why?
Chromosome Aberrations
1
2009
297
0.020
 Why?
Cell Differentiation
1
2011
681
0.020
 Why?
Survival Rate
1
2010
949
0.020
 Why?
Registries
1
2010
652
0.020
 Why?
Treatment Outcome
1
2017
5595
0.020
 Why?
Chromosomes, Human
1
2005
41
0.010
 Why?
Time Factors
1
2010
2991
0.010
 Why?
Reproducibility of Results
1
2005
1219
0.010
 Why?
Mice
1
2010
5982
0.010
 Why?
Animals
1
2010
13526
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (243) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department